Seminars in arthritis and rheumatism

01 17 October 2026

DOI 10.1016/j.semarthrit.2026.153071

Corrigendum to “Patient perspective on remission in rheumatoid arthritis: validation of patient reported outcome instruments to measure absence of disease activity” [Seminars in Arthritis and Rheumatism 51/6 (2021) 1360–1369]

Open DOI

L. Rasch, M. Boers, W. Lems et al.

02 11 October 2026

DOI 10.1016/j.semarthrit.2026.153087

Incidence and characteristics of cytokine release syndrome in patients with systemic sclerosis undergoing autologous haematopoietic stem cell transplantation

Open DOI

Charlotte S Schimmel, Eva M Hoekstra, Maaike Fm Koops et al.

03 9 October 2026

DOI 10.1016/j.semarthrit.2026.153088

Evolution of outcome assessment in clinical trials of rheumatoid arthritis: A scoping review

Open DOI

João Manuel Vieira Maciel-De-Sousa, Rafael França Lima, Melyssa Marry Duarte-Serejo et al.

04 4 October 2026

DOI 10.1016/j.semarthrit.2026.153085

Association of antenatal glucocorticoids with risk of autoimmune diseases in children: a nationwide cohort study

Open DOI

Tsung-Chieh Yao, Jih-Chang Yu, Yi-Fen Tsai et al.

05 26 September 2026

DOI 10.1016/j.semarthrit.2026.153084

Evidence-Informed Exercise Dose Targets for Rheumatoid Arthritis: A Systematic Review and Bayesian Dose–Response Network Meta-Analysis

Open DOI

Ran Huo, Haoran Luo, Wenhao Li et al.

06 23 September 2026

DOI 10.1016/j.semarthrit.2026.153083

Glucocorticoid discontinuation in patients with rheumatoid arthritis who initiated biologic or targeted synthetic agents: a real-world population-based analysis

Open DOI

Yingzhao Jin, Huan Meng, Steven H. Lam et al.

07 19 September 2026

DOI 10.1016/j.semarthrit.2026.153082

Comparative efficacy and safety of disease-modifying antirheumatic drugs tapering strategies in sustained-remission rheumatoid arthritis: Systematic review and network meta-analysis

Open DOI

Yosi Yohanes Putra Tandi, Muhammad Yasir Syafa'ATulloh, Yitzchak Millenard Sigilipu et al.

08 18 September 2026

DOI 10.1016/j.semarthrit.2026.153079

Consensus recommendations for optimal trial design and reporting of core domains in urate-lowering therapy trials for gout: A Delphi study

Open DOI

Ellen Prendergast, Nicola Dalbeth, Robin Christensen et al.

09 18 September 2026

DOI 10.1016/j.semarthrit.2026.153070

Corrigendum to “Patient perspective on remission in rheumatoid arthritis: validation of patient reported outcome instruments to measure absence of disease activity” [Seminars in Arthritis and Rheumatism 51/6 (2021) 1360–1369]

Open DOI

L. Rasch, M. Boers, W. Lems et al.

10 14 September 2026

DOI 10.1016/j.semarthrit.2026.153078

Cyclophosphamide vs rituximab induction therapy for ANCA-associated vasculitis. A systematic review and meta-analysis of 12-month mortality

Open DOI

Caroline Allan, Gursimran Kaur, Laila Girgis et al.